2024/03/28 18:00:02 | |
---|---|
Price | |
259.678 CHF | |
Difference | 2.28% (5.79) |
ISIN | US0311621009 |
Symbol | AMGN |
Exchange | BX Swiss |
Currency | CHF |
Sector | Chemical / Pharmaceutical / Health |
Security type | Stock |
Market cap (m) | 141,011 EUR |
Benchmark | S&P 500 |
Bid (Bid size) | 257.313 CHF (202) |
Ask (Ask size) | 257.793 CHF (202) |
Open | 259.678 CHF |
High | 259.678 CHF |
Low | 259.678 CHF |
Close (prev. day) | 253.889 CHF |
VWAP | 259.678 CHF |
Volume (pcs) | 8 |
Trading volume | 2,077.40 |
Number of trades | 1 |
Last size | 8 |
Related Futures | 15 |
Related Options | - |
Date | Headline | Download | |
2024/03/13 | Global Equity Ratings | ||
2024/02/22 | Global Equity Ratings | ||
2024/02/14 | Global Equity Ratings | ||
2024/01/23 | Global Equity Ratings | ||
2023/12/21 | Global Equity Ratings |
2024/03/28 18:00:02 | |
---|---|
Price | |
259.678 CHF | |
Difference | 2.28% (5.79) |
ISIN | US0311621009 |
Symbol | AMGN |
Exchange | BX Swiss |
Currency | CHF |
Sector | Chemical / Pharmaceutical / Health |
Security type | Stock |
Market cap (m) | 141,011 EUR |
Benchmark | S&P 500 |
Bid (Bid size) | 257.313 CHF (202) |
Ask (Ask size) | 257.793 CHF (202) |
Open | 259.678 CHF |
High | 259.678 CHF |
Low | 259.678 CHF |
Close (prev. day) | 253.889 CHF |
VWAP | 259.678 CHF |
Volume (pcs) | 8 |
Trading volume | 2,077.40 |
Number of trades | 1 |
Last size | 8 |
6m | 1Y | 3Y | |
Perf (%) | +9.96% | +22.20% | - |
Perf (abs.) | +23.53 | +47.18 | - |
Beta | 0.75 | 0.52 | 0.40 |
Volatility | 43.62 | 44.26 | - |
Ø price 5 days | Ø volume 5 days (pcs.) | 254.473 CHF (9) |
Ø price 30 days | Ø volume 30 days (pcs.) | 249.693 CHF (16) |
Ø price 100 days | Ø volume 100 days (pcs.) | 253.397 CHF (10) |
Ø price 250 days | Ø volume 250 days (pcs.) | 239.883 CHF (6) |
YTD High | date | 268.630 CHF (2024/01/26) |
YTD Low | date | 236.977 CHF (2024/03/08) |
52 Weeks High | date | 268.630 CHF (2024/01/26) |
52 Weeks Low | date | 198.514 CHF (2023/05/26) |
Exchange | Date | Time | Price | Trading volume (mio.) | Number of trades |
BX Swiss | 2024/03/28 | 18:00 | 259.678 CHF | 0.00 | 1 |
Berlin | 2024/03/28 | 08:08 | 264.00 EUR | 0.00 | 2 |
Duesseldorf | 2024/03/28 | 19:30 | 263.40 EUR | 0.00 | 7 |
Euronext Milan MTF Global Equity Market | 2024/03/28 | 17:44 | 265.00 EUR | 0.05 | 10 |
Euronext Milan MTF Trading After Hours | 2024/03/18 | 20:28 | 250.00 EUR | 0.00 | 1 |
Frankfurt | 2024/03/28 | 19:57 | 264.60 EUR | 0.08 | 8 |
Hamburg | 2024/03/28 | 10:45 | 267.20 EUR | 0.01 | 2 |
Hanover | 2024/03/28 | 17:03 | 266.00 EUR | 0.01 | 2 |
Hong Kong Stock Exchange | 2024/02/16 | 02:15 | 1,850.00 HKD | - | - |
London Stock Exchange | 2024/03/28 | 17:35 | 286.00 USD | 0.00 | 3 |
Munich | 2024/03/28 | 16:53 | 264.60 EUR | 0.07 | 2 |
Nasdaq | 2024/03/28 | 21:30 | 284.32 USD | 652.81 | 40,648 |
SIX Swiss Exchange | 2022/11/14 | 17:36 | 180.00 CHF | 0.00 | 1 |
SIX Swiss Exchange | - | - | - | 0.00 | - |
Stuttgart | 2024/03/28 | 12:36 | 267.20 EUR | 0.03 | 5 |
Tradegate | 2024/03/28 | 22:26 | 263.80 EUR | 0.72 | 94 |
Vienna Stock Exchange | 2024/03/28 | 17:32 | 264.40 EUR | 0.00 | 2 |
Xetra | 2024/03/28 | 17:35 | 264.40 EUR | 0.13 | 36 |
AMGEN INC. |
- - |
One Amgen Center Drive - 91320-1799 Thousand Oaks |
Telefon: +1-805-447-1000 |
Fax: +1-805-447-1010 |
E-mail: - |
Amgen, Inc. is a biotechnology company, which engages in the discovery, development, manufacture, and marketing of human therapeutics. It operates through Human Therapeutics segment. The company was founded by William K. Bowes, Jr., Franklin Pitcher Johnson, Jr., George B. Rathmann, and Joseph Rubinfeld on April 8, 1980 and is headquartered in Thousand Oaks, CA. |
Brian Druker | Member of Board of Directors |
Michael Drake | Member of Board of Directors |
Omar Ishrak | Member of Board of Directors |
Robert Williams | Member of Board of Directors |
Ronald Sugar | Member of Board of Directors |
Tyler Jacks | Member of Board of Directors |
Wanda Austin | Member of Board of Directors |
Amy Miles | Member of Board of Directors |
Charles Holley | Member of Board of Directors |
Ellen Kullman | Member of Board of Directors |
Greg Garland | Member of Board of Directors |
Robert Eckert | Member of Board of Directors |
Robert Bradway | Chairman of Managing Board |
Annalisa Pizzarello | Member of Executive Committee |
Anton Rabushka | Member of Executive Committee |
Arleen Paulino | Member of Executive Committee |
Darryl Sleep | Member of Executive Committee |
David A. Piacquad | Member of Executive Committee |
David M. Reese | Member of Executive Committee |
Esteban Santos | Member of Executive Committee |
Gilles Marrache | Member of Executive Committee |
Ian Thompson | Member of Executive Committee |
Jean-Charles Soria | Member of Executive Committee |
Jerry Murry | Member of Executive Committee |
Jonathan Graham | Member of Executive Committee |
Any information, material and services regarding financial instruments and securities provided by Česká spořitelna/Erste Group/ or any of its affiliates (collectively “Erste Group“) on this and any linked website hereafter (jointly the “Websites“) shall be exclusively to investors who are not subject to any legal sale or purchase restrictions.
By agreeing to this hereto, the visitor entering this Websites confirms that has read, understood and accepted this Information and the Disclaimer